Mabry, Iii
Clyde B. Mabry, Iii, Salisbury, NC US
Patent application number | Description | Published |
---|---|---|
20100054676 | Fiber Optic Furcation Assembly Having Feature(s) for Cable Management - Fiber optic cable assemblies having a fiber optic cable, a furcation body, and one or more furcated legs are disclosed herein. In embodiments disclosed herein, the furcation body comprises a first end and a second end opposite the first end, the first end having the fiber optic cable extending therefrom, and the second end having one or more furcated legs extending therefrom. The furcation body can include one or more features that facilitate cable management by supporting cabling components used in making fiber optic interconnections. The cable management features of the fiber optic cable assemblies advantageously inhibit sagging, facilitate access to fiber optic interconnections, and/or improve air flow paths between fiber optic interconnections. | 03-04-2010 |
20100086267 | Fiber Optic Cable Assemblies Employing a Furcation Body Having Anti-Rotation Feature - A fiber optic cable assembly including a fiber optic cable and a furcation body is disclosed. An attachment feature can be provided to mount the furcation body to a mounting surface of fiber optic equipment for securing a portion of the fiber optic cable assembly to the fiber optic equipment. The attachment feature may include an integrated anti-rotation feature to inhibit rotation of the furcation body with respect to a mounting surface. The anti-rotation feature is provided by one or more generally planar surfaces of the furcation body for abutting with at least one complementary planar mounting surface. | 04-08-2010 |
20100220967 | Hinged Fiber Optic Module Housing and Module - Embodiments disclosed include fiber optic module housings used for fiber optic modules. The fiber optic module housings comprise at least one hinge to allow a component of the housing to be opened and closed to allow easy access to the fiber optic module housing and/or its internal chamber. The hinge may be a living hinge disposed within a single part to allow each side of the living hinge to be bent or folded. The hinge may be disposed on a panel configured to support one or more fiber optic components to allow the panel to be opened and closed about the module housing for access. The fiber optic module housing may also be entirely comprised of a single part employing the use of living hinges between foldable parts. In this manner, no sides or parts of the fiber optic module housing need be provided as separate parts. | 09-02-2010 |
Clyde Benton Mabry, Iii, Hickory, NC US
Patent application number | Description | Published |
---|---|---|
20100126665 | LASER-BASED METHODS OF STRIPPING FIBER OPTIC CABLES - Laser-based methods of stripping different types of fiber optic cables ( | 05-27-2010 |
20100129043 | FIBER OPTIC DUST CAP ASSEMBLY AND METHOD - A fiber optic dust cap assembly for protecting fiber optic components is provided. The protected fiber optic components may include fiber optic adapters and fiber optic connectors. The fiber optic dust cap assembly includes a plurality of dust caps each coupled to a lanyard. Each of the plurality of dust caps is configured for insertion into a fiber optic component. The lanyard is configured to facilitate management of the dust caps. The lanyard is also configured to facilitate removal of the dust caps from the fiber optic components. Each of the dust caps among the plurality of dust caps may be removed by pulling on the lanyard. The lanyard may also facilitate removal of each of the plurality of dust caps in one pulling action. Additionally, by the plurality of dust caps being connected to the lanyard, the plurality of dust caps coupled to the lanyard remain together after removal. | 05-27-2010 |
George Robert Mabry, Iii, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20080299129 | ANTAGONISTS TO IL-17A, IL-17F, AND IL-23P19 AND METHODS OF USE - The present invention relates to blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-17A, IL-17F, and IL-23. Antagonists include antibodies and antibody fragments that bind IL-23 and that bind IL-17A or IL-17F, such as antibodies that are cross-reactive for IL-17A and Il-17F. Antagonists that include an antibody or antibody fragment that binds IL-23 and an antibody or antibody fragment that binds IL-17A or IL-17F on one molecule are also disclosed. Antibodies and antibody fragments that bind IL-23 and IL-17F but that do not bind IL-17A are also disclosed. IL-17 and IL-23 are cytokines that are involved in inflammatory processes and human disease. | 12-04-2008 |
20110159589 | METHODS OF INHIBITING INFLAMMATION WITH ANTAGONISTS TO IL-17A, IL-17F, AND IL-23P19 - The present invention relates to blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-17A, IL-17F, and IL-23. Antagonists include antibodies and antibody fragments that bind IL-23 and that bind IL-17A or IL-17F, such as antibodies that are cross-reactive for IL-17A and Il-17F. Antagonists that include an antibody or antibody fragment that binds IL-23 and an antibody or antibody fragment that binds IL-17A or IL-17F on one molecule are also disclosed. Antibodies and antibody fragments that bind IL-23 and IL-17F but that do not bind IL-17A are also disclosed. IL-17 and IL-23 are cytokines that are involved in inflammatory processes and human disease. | 06-30-2011 |
George Robert Mabry, Iii, Hanover, NH US
Patent application number | Description | Published |
---|---|---|
20120294862 | ANTAGONISTS OF IL-17A, IL-17F, AND IL-23P19 - The present invention relates to blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-17A, IL-17F, and IL-23. Antagonists include antibodies and antibody fragments that bind IL-23 and that bind IL-17A or IL-17F, such as antibodies that are cross-reactive for IL-17A and Il-17F. Antagonists that include an antibody or antibody fragment that binds IL-23 and an antibody or antibody fragment that binds IL-17A or IL-17F on one molecule are also disclosed. Antibodies and antibody fragments that bind IL-23 and IL-17F but that do not bind IL-17A are also disclosed. IL-17 and IL-23 are cytokines that are involved in inflammatory processes and human disease. | 11-22-2012 |